Serum and urinary progranulin in diabetic kidney disease

Detalhes bibliográficos
Autor(a) principal: Nicoletto, Bruna Bellincanta
Data de Publicação: 2016
Outros Autores: Krolikowski, Thaiana Cirino, Crispim, Daisy, Canani, Luis Henrique Santos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/149763
Resumo: Progranulin has been recognized as an adipokine related to obesity, insulin resistance and type 2 diabetes mellitus (T2DM). There are scarce data regarding progranulin and kidney disease, but there are some data linking diabetic kidney disease (DKD) and increased progranulin levels. We aimed to better describe the relationship between serum and urinary progranulin levels and DKD in T2DM. This is a case-control study including four groups of subjects: 1) Advanced DKD cases: T2DM patients with estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2; 2) Albuminuric DKD cases: T2DM patients with urinary albumin excretion (UAE) 30 mg/g creatinine and eGFR 60 mL/min/1.73m2; 3) Diabetic controls: T2DM patients with UAE <30 mg/g creatinine and eGFR 60 mL/min/1.73m2; and 4) Non-diabetic controls: individuals without T2DM. Progranulin was determined by enzymelinked immunosorbent assay. One hundred and fourteen patients were included (23 advanced DKD cases, 25 albuminuric DKD cases, 40 diabetic controls and 26 non-diabetic controls). Serum progranulin was increased in advanced DKD compared to other groups [70.84 (59.04±83.16) vs. albuminuric cases 57.16 (42.24±67.38), diabetic controls 57.28 (42.08±70.47) and non-diabetic controls 44.54 (41.44±53.32) ng/mL; p<0.001]. Urinary progranulin was decreased in advanced DKD cases compared to albuminuric cases [10.62 (6.30±16.08) vs. 20.94 (12.35±30.22); diabetic controls 14.06 (9.88±20.82) and non-diabetic controls 13.51 (7.94±24.36) ng/mL; p = 0.017]. There was a positive correlation between serum progranulin and body mass index (r = 0.27; p = 0.004), waist circumference (r = 0.25; p = 0.007); body fat percentage (r = 0.20; p = 0.042), high-sensitive C reactive protein (r = 0.35; p<0.001) and interleukin-6 (r = 0.37; p<0.001) and a negative correlation with eGFR (r = -0.22; p = 0.023). Urinary progranulin was positively associated with albuminuria (r = 0.25; p = 0.010). In conclusion, progranulin is affected by a decrease in eGFR, being at a higher concentration in serum and lower in urine of DKD patients with T2DM and eGFR <60 mL/min/1.73m2. It is also associated with markers of obesity and inflammation.
id UFRGS-2_95b969f3bc05b31523bc98a189017148
oai_identifier_str oai:www.lume.ufrgs.br:10183/149763
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Nicoletto, Bruna BellincantaKrolikowski, Thaiana CirinoCrispim, DaisyCanani, Luis Henrique Santos2016-11-19T02:17:00Z20161932-6203http://hdl.handle.net/10183/149763001007000Progranulin has been recognized as an adipokine related to obesity, insulin resistance and type 2 diabetes mellitus (T2DM). There are scarce data regarding progranulin and kidney disease, but there are some data linking diabetic kidney disease (DKD) and increased progranulin levels. We aimed to better describe the relationship between serum and urinary progranulin levels and DKD in T2DM. This is a case-control study including four groups of subjects: 1) Advanced DKD cases: T2DM patients with estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2; 2) Albuminuric DKD cases: T2DM patients with urinary albumin excretion (UAE) 30 mg/g creatinine and eGFR 60 mL/min/1.73m2; 3) Diabetic controls: T2DM patients with UAE <30 mg/g creatinine and eGFR 60 mL/min/1.73m2; and 4) Non-diabetic controls: individuals without T2DM. Progranulin was determined by enzymelinked immunosorbent assay. One hundred and fourteen patients were included (23 advanced DKD cases, 25 albuminuric DKD cases, 40 diabetic controls and 26 non-diabetic controls). Serum progranulin was increased in advanced DKD compared to other groups [70.84 (59.04±83.16) vs. albuminuric cases 57.16 (42.24±67.38), diabetic controls 57.28 (42.08±70.47) and non-diabetic controls 44.54 (41.44±53.32) ng/mL; p<0.001]. Urinary progranulin was decreased in advanced DKD cases compared to albuminuric cases [10.62 (6.30±16.08) vs. 20.94 (12.35±30.22); diabetic controls 14.06 (9.88±20.82) and non-diabetic controls 13.51 (7.94±24.36) ng/mL; p = 0.017]. There was a positive correlation between serum progranulin and body mass index (r = 0.27; p = 0.004), waist circumference (r = 0.25; p = 0.007); body fat percentage (r = 0.20; p = 0.042), high-sensitive C reactive protein (r = 0.35; p<0.001) and interleukin-6 (r = 0.37; p<0.001) and a negative correlation with eGFR (r = -0.22; p = 0.023). Urinary progranulin was positively associated with albuminuria (r = 0.25; p = 0.010). In conclusion, progranulin is affected by a decrease in eGFR, being at a higher concentration in serum and lower in urine of DKD patients with T2DM and eGFR <60 mL/min/1.73m2. It is also associated with markers of obesity and inflammation.application/pdfengPLoS ONE. San Francisco. Vol. 11, no. 10 (Oct. 2016), e0165177, 15 p.Nefropatias diabéticasDiabetes mellitus tipo 2ObesidadeSerum and urinary progranulin in diabetic kidney diseaseEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL001007000.pdf001007000.pdfTexto completo (inglês)application/pdf1414804http://www.lume.ufrgs.br/bitstream/10183/149763/1/001007000.pdff7ca70ffa37fdce14e2ed441cf6eafe4MD51TEXT001007000.pdf.txt001007000.pdf.txtExtracted Texttext/plain37769http://www.lume.ufrgs.br/bitstream/10183/149763/2/001007000.pdf.txtca31fade856172a4435f75d8184bf402MD52THUMBNAIL001007000.pdf.jpg001007000.pdf.jpgGenerated Thumbnailimage/jpeg2060http://www.lume.ufrgs.br/bitstream/10183/149763/3/001007000.pdf.jpgb29ba1757e44fa2ad214e3debc1ef40cMD5310183/1497632023-05-20 03:50:35.445475oai:www.lume.ufrgs.br:10183/149763Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2023-05-20T06:50:35Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Serum and urinary progranulin in diabetic kidney disease
title Serum and urinary progranulin in diabetic kidney disease
spellingShingle Serum and urinary progranulin in diabetic kidney disease
Nicoletto, Bruna Bellincanta
Nefropatias diabéticas
Diabetes mellitus tipo 2
Obesidade
title_short Serum and urinary progranulin in diabetic kidney disease
title_full Serum and urinary progranulin in diabetic kidney disease
title_fullStr Serum and urinary progranulin in diabetic kidney disease
title_full_unstemmed Serum and urinary progranulin in diabetic kidney disease
title_sort Serum and urinary progranulin in diabetic kidney disease
author Nicoletto, Bruna Bellincanta
author_facet Nicoletto, Bruna Bellincanta
Krolikowski, Thaiana Cirino
Crispim, Daisy
Canani, Luis Henrique Santos
author_role author
author2 Krolikowski, Thaiana Cirino
Crispim, Daisy
Canani, Luis Henrique Santos
author2_role author
author
author
dc.contributor.author.fl_str_mv Nicoletto, Bruna Bellincanta
Krolikowski, Thaiana Cirino
Crispim, Daisy
Canani, Luis Henrique Santos
dc.subject.por.fl_str_mv Nefropatias diabéticas
Diabetes mellitus tipo 2
Obesidade
topic Nefropatias diabéticas
Diabetes mellitus tipo 2
Obesidade
description Progranulin has been recognized as an adipokine related to obesity, insulin resistance and type 2 diabetes mellitus (T2DM). There are scarce data regarding progranulin and kidney disease, but there are some data linking diabetic kidney disease (DKD) and increased progranulin levels. We aimed to better describe the relationship between serum and urinary progranulin levels and DKD in T2DM. This is a case-control study including four groups of subjects: 1) Advanced DKD cases: T2DM patients with estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2; 2) Albuminuric DKD cases: T2DM patients with urinary albumin excretion (UAE) 30 mg/g creatinine and eGFR 60 mL/min/1.73m2; 3) Diabetic controls: T2DM patients with UAE <30 mg/g creatinine and eGFR 60 mL/min/1.73m2; and 4) Non-diabetic controls: individuals without T2DM. Progranulin was determined by enzymelinked immunosorbent assay. One hundred and fourteen patients were included (23 advanced DKD cases, 25 albuminuric DKD cases, 40 diabetic controls and 26 non-diabetic controls). Serum progranulin was increased in advanced DKD compared to other groups [70.84 (59.04±83.16) vs. albuminuric cases 57.16 (42.24±67.38), diabetic controls 57.28 (42.08±70.47) and non-diabetic controls 44.54 (41.44±53.32) ng/mL; p<0.001]. Urinary progranulin was decreased in advanced DKD cases compared to albuminuric cases [10.62 (6.30±16.08) vs. 20.94 (12.35±30.22); diabetic controls 14.06 (9.88±20.82) and non-diabetic controls 13.51 (7.94±24.36) ng/mL; p = 0.017]. There was a positive correlation between serum progranulin and body mass index (r = 0.27; p = 0.004), waist circumference (r = 0.25; p = 0.007); body fat percentage (r = 0.20; p = 0.042), high-sensitive C reactive protein (r = 0.35; p<0.001) and interleukin-6 (r = 0.37; p<0.001) and a negative correlation with eGFR (r = -0.22; p = 0.023). Urinary progranulin was positively associated with albuminuria (r = 0.25; p = 0.010). In conclusion, progranulin is affected by a decrease in eGFR, being at a higher concentration in serum and lower in urine of DKD patients with T2DM and eGFR <60 mL/min/1.73m2. It is also associated with markers of obesity and inflammation.
publishDate 2016
dc.date.accessioned.fl_str_mv 2016-11-19T02:17:00Z
dc.date.issued.fl_str_mv 2016
dc.type.driver.fl_str_mv Estrangeiro
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/149763
dc.identifier.issn.pt_BR.fl_str_mv 1932-6203
dc.identifier.nrb.pt_BR.fl_str_mv 001007000
identifier_str_mv 1932-6203
001007000
url http://hdl.handle.net/10183/149763
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv PLoS ONE. San Francisco. Vol. 11, no. 10 (Oct. 2016), e0165177, 15 p.
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/149763/1/001007000.pdf
http://www.lume.ufrgs.br/bitstream/10183/149763/2/001007000.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/149763/3/001007000.pdf.jpg
bitstream.checksum.fl_str_mv f7ca70ffa37fdce14e2ed441cf6eafe4
ca31fade856172a4435f75d8184bf402
b29ba1757e44fa2ad214e3debc1ef40c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801224910738030592